PubMed Health⌕ Search

Biomedical subjects

Rudi Dierckx

Publications and source records attributed to Rudi Dierckx.

At least 37 records · Page 2Linked to original sources
PubMed2003

Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150.

Impulsive aggression in dogs has an important impact on human public health. Better insight into the pathophysiology of this phenomenon could lead to more adequate diagnosis and treatment. Indirect in vivo research on peripheral body fluids and post-mortem studies in impulsive animals and humans indicate a deficient serotonergic system in general and disturbances in the serotonin-2A (5-HT2A) receptor in particular. In this study, brain perfusion and the 5-HT2A receptors were examined in impulsive, aggressive dogs, in comparison with a group of normally behaving animals. In order to decide which dogs to include in this study, owners were asked to describe the general behaviour of the dogs, the circumstances in which aggression occurred and their conduct during aggressive acts. Finally, 19 dogs were retained for this study, showing, according to different behavioural specialists, disinhibited dominance aggression. Functional imaging studies were performed on all these dogs. Single-photon emission tomography (SPET) was used to measure regional brain perfusion using technetium-99m labelled ethyl cysteinate dimer (ECD). The 5-HT2A receptor binding properties were investigated using the selective radioligand iodine-123 labelled 5-I-R91150. A significant increase in uptake of the 5-HT2A radioligand was noted in all cortical areas. No significant alterations were found in regional cortical perfusion, indicating that the increased binding index was not a consequence of increased tracer delivery. This study supports a role for the serotonergic system in canine impulsive aggression.

Aggression↗
PubMed2003

18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine.

BACKGROUND: Using conventional imaging methods, including magnetic resonance imaging and labeled leukocyte scanning, the diagnosis of infection in the postoperative spine remains a diagnostic challenge. Recently, promising results have been reported using 18F-fluorodeoxyglucose positron emission tomography for various infectious problems. This study aimed to investigate the value of 18F-fluorodeoxyglucose positron emission tomography in patients suspected of having spinal infection after previous surgery of the spine. METHODS: Fifty-seven consecutive patients with a history of previous spinal surgery were prospectively included between February 1999 and June 2001. 18F-fluorodeoxyglucose positron emission tomography was performed 60 to 90 minutes after injection of 370 MBq 18F-fluorodeoxyglucose. Images were scored visually and semiquantitatively by two blinded, independent, certified nuclear medicine physicians, experienced with positron emission tomography. Differences were assessed by consensus. Results were correlated with final diagnosis allowing calculation of sensitivity, specificity and accuracy. Receiver operating characteristic analysis was performed to find optimal cut-off values. RESULTS: Fifteen patients had spinal infection. Using the most sensitive cut-off values sensitivity, specificity and accuracy were 100%, 81%, and 86%, respectively, for both visual and semiquantitative scoring. In the group without metallic implants (n = 27), false positives (n = 2) only occurred in the first 6 months after surgery. In the group with metallic implants (n = 30), false positives (n = 6) were not confined to recently operated patients. CONCLUSIONS: Overall accuracy was excellent (86%) with a negative predictive value of 100%. 18F-fluorodeoxyglucose positron emission tomography holds promise to become the standard imaging technique in this difficult patient population, as it is straightforward, provides a rapid result (2 hours) and because accurate alternatives are lacking.

Adolescent↗
PubMed2003

False-negative Tc-99m MIBI scintigraphy in histopathologically proved recurrent high-grade oligodendroglioma.

Tc-99m MIBI is a small lipophilic radioligand that enters cells by diffusion and is preferentially trapped in mitochondria. As a result of the high mitochondrial activity in tumors, Tc-99m MIBI accumulates significantly more in tumor tissue compared with normal tissues. Accordingly, Tc-99m MIBI has been used successfully to visualize primary, metastatic, and recurrent tumor. In brain tumors, Tc-99m MIBI SPECT has been shown to identify tumor recurrence after treatment in high-grade gliomas. In this report, early (30 minutes after injection) and delayed (4 hours after injection) Tc-99m MIBI SPECT did not visualize a histopathologically proved recurrent high-grade oligodendroglioma. Increased vascular supply, disruption of the blood-brain barrier, high-grade cancer, and viability of tumor cells are decisive factors related to increased Tc-99m MIBI uptake in brain tumors. However, the authors' results suggest that still other mechanisms may be involved in Tc-99m MIBI accumulation, which may account for false-negative imaging in brain tumors.

Adult↗
PubMed2003

The dilemma of being a physician-patient.

Being either a physician or a relative to a physician on the occasion of having a disease needing help from another physician, the physician-patient situation, can trigger some problems which are different from the normal doctor-patient relationship. Some aspects of this are an incorrect diagnostic approach (either hyper- or hypo-diagnostics) and an inadequate therapeutic regimen. Others are mainly based on the peer situation of the two parties involved. Awareness of the special physician-patient situation in the treating physician could be one step out of the dilemma.

Attitude↗
PubMed2003

The exceptional brain of Maurice Ravel.

This historical review describes the brain disease which afflicted the great impressionist-classicist composer Maurice Ravel (1875-1937). The usual interpretation of the symptoms Ravel exhibited during his disease is primary progressive aphasia / Pick's disease. Some authors see this as the cause for his lost musical creativity during the last years of his life. By contrast, in our review it is presented why a car accident in 1932, with the probable consequence of a mild to moderate traumatic brain injury, could be the key event in his life, triggering the loss of his ability to compose. In addition, the influence of Ravel's disease on his musical style is evaluated. Although some authors see a link, we try to explain why there is no clear evidence for this.

Brain Injuries↗
PubMed2003

The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage.

Dose-effect calculations used in the planning of modern radiotherapy (RT) involving normal lung or cardiac tissue rely on structural imaging techniques, such as CT, as the basis for measuring and predicting dose-response. However, more accurate methods for predicting dose-response may result if information on the locoregional functional status of the irradiated organ(s) is included in the computational model. For RT cases that involve delivering dose to the lung and heart, this may be achieved by the assessment of tomographic scintigraphies of lung perfusion (Q) and ventilation (V) and scintigraphic imaging of myocardial perfusion and function, respectively.

Breast Neoplasms↗
PubMed2003

Imaging of mild traumatic brain injury using 57Co and 99mTc HMPAO SPECT as compared to other diagnostic procedures.

BACKGROUND: Traumatic brain injury (TBI) is usually assessed with the Glasgow Coma Scale (GCS), CT and EEG. TBI can result from either the primary mechanical impact or secondary (ischemic) brain damage, in which calcium (Ca) plays a pivotal role. This study was undertaken to compare the applicability of SPECT using 57Co as a Ca-tracer in patients with mild traumatic brain injury. MATERIAL/METHODS: 8 patients with mild TBI (GCS 15) were clinically examined and studied with EEG, neuropsychological testing (NPT) and SPECT within 2 days post-TBI. After i.v.-administration of 37 MBq (1 mCi) 57Co (effective radiation dose 0.34 mSv x MBq(-1); 1.24 rem x mCi(-1); physical half-life 270 days, biological half-life 37.6 h), single-headed SPECT (12 h pi) was performed, consecutively followed by standard 925 MBq (25 mCi) Tc-99m HMPAO SPECT. RESULTS: In 6 of the 8 patients, baseline NPT and SPECT showed focal abnormalities in the affected frontal and temporal brain regions, which were in good topographical accordance. CT and EEG did not detect (structural) lesions in any of these cases. CONCLUSIONS: Single-headed 57Co-SPECT is able to show the site and extent of brain damage in patients with mild TBI, even in the absence of structural lesions. It may confirm and localize NPT findings. The predictive value of 57Co-SPECT should be assessed in larger patient series.

Adolescent↗
PubMed2002

Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies?

In the presurgical evaluation of patients with partial epilepsies, the most extensively studied functional neuro-imaging modality to define the origin of seizure onset is fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET). Generally, this technique reveals a widespread zone of interictal glucose hypometabolism in the region of the epileptogenic focus. However, the technique may miss the epileptogenic region and FDG PET abnormalities may extend beyond the seizure onset zone. Consequently, for the precise identification of epileptogenic regions more specific imaging probes than FDG are warranted. This review considers the clinical utility of iomazenil (IMZ) SPET and flumazenil (FMZ) PET for the precise localization of epileptogenic foci in partial epilepsy syndromes.

Brain↗
PubMed2002

Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans.

Pre-therapeutic metaiodobenzylguanidine (MIBG) scans can be performed using labelling with either iodine-123 or iodine-131. (123)I-MIBG scans provide better image quality and count statistics, while (131)I-MIBG allows registration of tracer kinetics over a longer period. The aim of this study was to determine how much information about the (131)I-MIBG therapy total body dose according to the MIRD formalism can be gathered from (123)I-MIBG pre-therapy scans. Thirty-eight (131)I-MIBG therapies administered to a total of 15 patients suffering from neuroblastoma ( n=6), carcinoid tumours ( n=5), phaeochromocytoma ( n=3) and medullary thyroid carcinoma ( n=1) were included. The mean administered activity was 5.3 GBq (SD 2.4 GBq). Three biplanar (123)I-MIBG total body scans were taken only once before a series of therapies while three biplanar (131)I-MIBG scans were taken after each therapy. Attenuation correction was performed taking into account the difference in attenuation between (123)I and (131)I. Using the MIRD formalism, the total body dose to the patient was calculated on the basis of: (1) a single exponential fit drawn through the data from the (123)I-MIBG pre-therapy scans, (2) a bi-exponential fit through the combined data of (123)I-MIBG pre-therapy and (131)I-MIBG post-therapy scans. The mean total body dose calculated in our study was significantly higher for patients suffering from neuroblastoma (mean+/-SD 0.37+/-0.21 mGy/MBq) than for patients suffering from phaeochromocytoma (0.08+/-0.02 mGy/MBq), carcinoid tumours (0.07+/-0.01 mGy/MBq) and medullary thyroid carcinoma (0.09 mGy/MBq). The correlation coefficient between the dose calculated on the basis of the (123)I-MIBG pre-therapy scans and the subsequent (131)I-MIBG therapy was 0.93 when a correction factor of 1.26 was taken into account. When considering all following therapies, the correlation was 0.85 and the correction factor, 1.20. Our results show that it is feasible to use data from pre-therapy (123)I-MIBG scans to calculate the total body dose of the subsequent (131)I-MIBG therapy.

3-Iodobenzylguanidine↗
PubMed2002

Patients' and personnel's perceptions of service quality and patient satisfaction in nuclear medicine.

Patients' and personnel's perceptions of service quality were analysed to position nuclear medicine organisations in the service triangle theory of Haywood-Farmer [ Int J Production and Operations Management 1988; 6:19-29]. After distinguishing the service quality dimensions of nuclear medicine, a comparison was made between the service quality perceptions of patients ( n=259) and those of personnel ( n=24). We examined the importance of different service quality dimensions by studying their relationship to patient satisfaction. The proposed five dimensions of SERVQUAL, the most commonly used service quality measurement scale, were not confirmed. Patients considered tangibles and assurance as one dimension, while the original empathy dimension was separated into empathy and convenience. Personnel perceived all service quality dimensions as less good than did patients, except for empathy. Results indicated that patients' perception of service quality was correlated with patient satisfaction, especially in terms of reliability and tangibles-assurance. Based on these service quality dimensions, we suggest that nuclear medicine services need to optimise their physical and process component and the technical skills of personnel.

Adolescent↗
PubMed2002

Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography.

Normal aging is associated with a decrease in number and size of neurons, loss of synapses and neuronal branching and with a reduced functioning neurotransmitter systems, such as the serotonergic system. These structural and functional alterations have important impact on the behavioural, cognitive and affective status of the individual. With the introduction of functional brain imaging in veterinary medicine, the canine brain can be examined in vivo, evaluating changes in perfusion, metabolism and neurotransmitter systems. Since cognitive decline is recognised in the aging dog, it was our aim to investigate whether age related changes concerning cerebral perfusion and binding index of the selective 5-HT2A receptor ligand 123I-5-I-R91150 could be found in the canine brain. A group of twelve normal, aging dogs, older than 96 months, was compared to a normal reference group (n = 12), younger than 96 months. SPET images were obtained, using the radiopharmaceutical 99mTc-N,N''-1,2-ethylene-diylbis-L-cysteine diethylester dihydrochloride (99mTc-ECD) for evaluation of the regional perfusion and the selective radioligand 123I-5-I-R91150 for visualization of the 5-HT2A receptor. Regional decrease of cerebral blood-flow was noted in the fronto- and temporocortical area and in the subcortical region. Age was negatively correlated with perfusion in the left and right fronto-cortical region. The binding index of the neuroreceptor radioligand was decreased in the fronto-cortical region, with a significant negative correlation with age in the right fronto-cortical area. No correlation was found between alteration of perfusion and binding index of the receptor ligand, suggesting that age related perfusion differences do not influence the binding of this radioligand. These results suggest that age related effects should be considered in functional canine brain imaging.

Aging↗
PubMed2002

Nuclear medicine imaging for prediction or early assessment of response to chemotherapy in patients suffering from breast carcinoma.

Reliable assays that could assess treatment response more rapidly or even predict responsiveness of breast tumours to chemotherapy would be very valuable as they would allow for adjustment of ineffective treatment and discontinuation of ineffective treatment in an early phase. As with effective cancer therapy, changes in tumour physiology, metabolism and proliferation do often precede volumetric changes routinely measured by morphological imaging modalities, for example, radiography and computerized tomography, assessment of these parameters by means of single photon emission computerized tomography (SPECT) or positron emission tomography may provide more sensitive and earlier markers of tumour cell death or growth inhibition. This paper reviews the available literature on the role of SPECT and PET in the measurement and visualisation of breast tumour metabolism (glucose utilization and protein synthesis rate), apoptosis induction and chemotherapy resistance mechanisms as predictors or early markers of tumour response or non-response to chemotherapeutic options in patients suffering from breast carcinoma.

Apoptosis↗